Navigation Links
Novexel Reports Positive Phase II Trial Results With NXL103 in Adult Patients With Community Acquired Pneumonia
Date:10/23/2008

PARIS, October 23 /PRNewswire/ -- Novexel, a speciality pharmaceutical company focused on the discovery and development of novel antibiotics designed to overcome the significant global problem of microbial resistance, announces positive results from its Phase II clinical trial evaluating NXL103 in the treatment of community acquired pneumonia (CAP). NXL103 is a novel oral streptogramin antibiotic that has potent in vitro activity against certain Gram positive bacteria including methicillin resistant Staphylococcus aureus (MRSA) as well as the important respiratory pathogens including penicillin, macrolide and quinolone resistant strains.

The NXL103 Phase II study was a double-blind, multinational, randomized, comparative study that evaluated this novel oral antibacterial as a treatment for mild to moderate CAP. The study recruited 300 adult patients in 9 countries in both the Northern and Southern hemispheres. Patients were randomised (1:1:1) to three treatment arms: 500mg of NXL103 twice a day, 600mg NXL103 twice a day or 1,000 mg of amoxicillin three times a day for 7 days. The key endpoints of the study were the clinical outcome in the clinically evaluable population at the early follow-up visit (7 to 14 days post-therapy) and safety. In this study, both doses of NXL103 were effective, with clinical response rates similar to those seen in the amoxicillin group. For the primary efficacy analysis, response rates were 91.4% in the 500mg NXL103 group; 94.7% in the 600mg NXL103 group; and 88.5% in the amoxicillin group. NXL103 was generally well tolerated with the most frequent adverse events related to gastrointestinal intolerance. There were no serious drug-related adverse events reported in the study.

The complete results from this Phase II trial will be published in the first half of 2009.

NXL103 has a spectrum of activity that indicates it has the potential to be effective in the treatment of skin and skin structure infections, includi
'/>"/>

SOURCE Novexel
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Genmab A/S - Company Announcement: Genmab Reports Results of Portfolio
2. Genaera Corporation Reports Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting
3. Alimera Reports Results From the Six-Month Interim Readout of the Human PK Iluvien(TM) Study
4. BioView Reports Interim Results of Early Detection Lung Cancer Diagnostic Test
5. Bioheart Reports Promising Results From Preclinical Study of Adipose-Derived Acute Cell Therapy
6. MannKind Reports Positive Data from a Phase 3 Clinical Study of Technosphere Insulin in Type 1 Diabetes
7. Bionovo Reports on Metabolic Studies Related to Its Menopausal Hot Flash Drug Candidate
8. Nutrition 21 Reports That National Toxicology Program Studies Support the Safety of Chromium Picolinate
9. Human Genome Sciences Reports Initial Results of Randomized Phase 2 Trial of HGS-ETR1 in Combination With Bortezomib in Advanced Multiple Myeloma
10. Regado Biosciences Reports Clinical Results for REG1 Anticoagulation System at European Society of Cardiology Congress 2008
11. Algeta Reports Positive Headline Phase II Data on Pain Palliation With Alpharadin
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... DIEGO , Aug. 29, 2014   ... emerging biopharmaceutical company, announced today that Santosh Vetticaden, ... be leaving the Company, for personal reasons, in ... Chief Medical Officer of Aires Pharmaceuticals, which Mast ... former responsibilities as the Company,s interim Chief Medical ...
(Date:8/29/2014)... 29, 2014 Medina Medical announced today that ... of the Board of Directors on August 18, 2014. ... and commercialization experience, including over a decade of direct ... as a Partner of the medical device incubator The ... two Foundry start-ups. Mr. Engelson previously served as the ...
(Date:8/29/2014)... , Aug. 29, 2014 Thoratec Corporation ... device-based mechanical circulatory support therapies to save, support and ... in the 2014 Morgan Stanley Global Healthcare Conference on ... , President and Chief Executive Officer, will provide an ... Daylight Time (9:55 a.m., Pacific Daylight Time).   ...
Breaking Medicine Technology:Mast Therapeutics Announces Management Change 2Mast Therapeutics Announces Management Change 3Mast Therapeutics Announces Management Change 4Medina Medical Announces Erik T. Engelson Joins as Chief Executive Officer 2
... On Monday, in a disappointing move, the U.S. Food and ... Agency to ban certain uses of antibiotics in food animals.  ... to withdraw the approvals for antibiotics given to animals in ... the antibiotics are also used in human medicine. The petitions ...
... Care , the only children,s hospice program serving Los Angeles ... courtesy of Toyota,s 100 Cars for Good program, which awarded ... deserving non-profit organizations. The Sienna minivan for Providence is one ... Toyota to better assist those who are mobility-impaired, whether due ...
Cached Medicine Technology:FDA Denies Citizen Petitions on Animal Antibiotics 2Toyota 100 Cars for Good Program Helps Fill Need for Mobility Vehicles 2Toyota 100 Cars for Good Program Helps Fill Need for Mobility Vehicles 3Toyota 100 Cars for Good Program Helps Fill Need for Mobility Vehicles 4Toyota 100 Cars for Good Program Helps Fill Need for Mobility Vehicles 5Toyota 100 Cars for Good Program Helps Fill Need for Mobility Vehicles 6
(Date:8/29/2014)... August 29, 2014 Pursuing its deepest ... set to unveil a stunning new design that promises ... figures, the highly notable surrogacy platform has witnessed a ... over 13,000 visitors a month, the FindSurrogateMother.com community is ... toward one common goal — the precious gift of ...
(Date:8/29/2014)... (PRWEB) August 29, 2014 Carson Hearing ... to provide hearing health care tips to local residents ... blog section will offer weekly articles from the audiologists ... topics including the latest advances in hearing restoration research, ... questions. The audiologists plan to write a new post ...
(Date:8/29/2014)... Mirada, CA (PRWEB) August 29, 2014 ... healthcare organizations, acquired a new medical center from LAXMed. The ... airport and less than 2 miles west of the 405 ... center within Southern California. The new LAX center is located ... 90045. , The new Healthpointe LAX office ...
(Date:8/29/2014)... News) -- If you have bunions, taking care of them ... expert says. A bunion is a bump that forms ... tissue moves out of place and extends beyond the normal ... pain and may require surgery to correct, said Brent Rosenthal, ... Freehold, N.J. To prevent bunions, avoid wearing shoes with ...
(Date:8/29/2014)... clinical trials based on administering antidepressants for acute ... more trials are needed to determine whether these ... a regular basis., Dr. Ian Gilron, a professor ... Department of Anesthesiology, and his team of seven ... use of antidepressants for pain relief post-surgery would ...
Breaking Medicine News(10 mins):Health News:FindSurrogateMother.com Set to Unveil Stunning New Design as Member Sign-ups Increase by 42% since January 2Health News:FindSurrogateMother.com Set to Unveil Stunning New Design as Member Sign-ups Increase by 42% since January 3Health News:Fort Worth Hearing Aid Leader, Carson Hearing Care, Creates Expert Blog to Discuss Important Hearing Healthcare Topics 2Health News:Fort Worth Hearing Aid Leader, Carson Hearing Care, Creates Expert Blog to Discuss Important Hearing Healthcare Topics 3Health News:Healthpointe Obtains a New Medical Clinic in the LAX Area 2Health News:Take Steps to Control Bunions 2Health News:Antidepressants show potential for postoperative pain 2
... has banned its government buildings from turning on air ... Fahrenheit), state media reported. ,Nanjing, capital of ... a limit on air conditioning use as pressure from ... effect over fears of power failures this summer. ...
... after a slimming product company approached her for the product's ... is the brand ambassador of diet shake SlimFast. ,However, ... when the brand came up with the proposal. ,"I ... Contactmusic quoted her, as saying. ,Meanwhile, The supermodel is ...
... be at risk from the impact of climate change, feel ... United Nations to act quickly on the matter, groups like ... body to list the locations as being "in danger". ... have a legal duty to cut emissions, the campaigners were ...
... insulation, anyone? Eben Bayer of Vermont and his colleague ... ,The two have together created and already patented ... flour, oyster mushroom spores and perlite, a mineral blend ... soon be part of the growing market for eco-friendly ...
... program delivered by mail is more effective than one-on-one ... active, simple programs that provide feedback and motivation can ... a good start. ,Researchers found feedback delivered ... activity in the short-term and potentially more effective long-term ...
... about six years ago, methamphetamine use was seen mostly in ... expanded rapidly throughout the rest of the country and across ... abuse across the United States has been as rapid as ... 2005 National Survey on Drug Use and Health (NSDUH), an ...
Cached Medicine News:Health News:Everest, Five Other World Heritage Sites Face Climate Change Risk 2Health News:US Whizkids Create Eco-friendly Building Material from Mushroom 2Health News:US Whizkids Create Eco-friendly Building Material from Mushroom 3Health News:Physical Activity can Be Increased by a Motivating Mail 2Health News:Physical Activity can Be Increased by a Motivating Mail 3Health News:Chronic Metamphetamine Abuse is Related to Cardiovascular Disease 2
Immunofluorescence test for detecting RSV in direct specimens and cultures....
... EZ RSV Test utilizes a new, improved format ... for rapid RSV detection. The testing device employs ... dried reagents have already been applied to the ... process, with clear-cut results shown by the appearance ...
Qualitative ELISA for the detection of rotavirus antigen....
A direct enzyme immunoassay for detection of gr. A rotavirus in fecal specimens....
Medicine Products: